USD10
AZN Shares
About AstraZenecaA merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
USD10
AZN Shares
About AstraZenecaA merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Stats
TRADING WINDOW
Closed
OPENS AT
Not enough data
MARKET CAP
$250.34B
OPEN PRICE
$162.14
LOW (1Y)
$141.77
HIGH (1Y)
$212.71
LOW (24H)
$160.00
HIGH (24H)
$162.18
VOLUME (24H)
$3.73M
58.26%
Price history
Time | Price | Change |
|---|---|---|
Today | $162.14 | |
1 Day | $160.01 | |
1 Week | $169.29 | |
1 Month | $193.10 | |
1 Year | $74.07 |
Past performance is not a reliable indicator of future results.
Discover more
Popular prediction markets
Legal
Information is provided for informational purposes only, and is not investment advice. This is not an invitation, inducement or recommendation to buy any particular asset, or to employ any particular investment strategy. Coinbase makes no representation as to the accuracy, suitability or validity of any information provided.All ticker names are trademarks of their respective holders. Any ticker reference does not imply affiliate with or endorsement by a third-party. Real-time prices are sourced from third parties, but not from all markets. Source: Nasdaq Last Sale. Morningstar data ©2026.
